Company news
Neurogene Inc. news in 2020
Neurogene Inc.'s news releases, calls and decks from 2020, newest first.
Neoleukin Therapeutics Announces Submission of Investigational New Drug Application for NL-201 De Novo Protein Immunotherapy Candidate for Cancer
December 9, 2020
Neoleukin Therapeutics Announces Participation in Piper Sandler 32nd Annual Virtual Healthcare Conference
November 22, 2020
Neoleukin Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
November 10, 2020
Neoleukin Therapeutics Presents Preclinical Combination Data for NL-201 at Society for Immunotherapy of Cancer’s 35th Anniversary Annual Meeting (SITC 2020)
November 9, 2020
Neoleukin Therapeutics Announces Third Quarter 2020 Financial Results and Corporate Update
November 8, 2020
Neoleukin Therapeutics Announces Publication in Science of De Novo Protein Decoys that Block COVID-19 Infection In Vitro and Protect Animals In Vivo
November 4, 2020